Premium
Avantor Inc (AVTR)
NYSE
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-08 | Mr. Gregory Thomas LucierIndependent Director | 10,00k | 83,20k | Achat | 8,32 | 60,00k | 20,00% |
| 2026-05-01 | Mr. Simon P. DingemansIndependent Director | 25,00k | 203,50k | Achat | 8,14 | 31,23k | 401,61% |
| 2026-03-10 | Mr. Sanjeev Kishen MehraIndependent Director | 125,00k | 1,00M | Achat | 8,01 | 475,00k | 35,71% |
| 2026-02-23 | Mr. R. Brent JonesInitié | -2,81k | 24,94k | Sale to Issuer | 8,89 | 39,95k | -6,56% |
| 2026-02-23 | Mr. Claudius O. SokenuExec. VP, Corporate Secretary and Chief Legal & Compliance Officer | -2,38k | 21,12k | Sale to Issuer | 8,89 | 16,89k | -12,33% |
| 2026-02-23 | Mr. Steven W. EckSenior VP, Interim CFO, Corporate Controller & CAO | -2,47k | 22,05k | Sale to Issuer | 8,89 - 9,11 | 99,33k | -2,43% |
| 2026-02-23 | Mr. Benoit GourdierExec. VP of Bioscience Production | -3,03k | 26,93k | Sale to Issuer | 8,89 | 24,86k | -10,86% |
| 2026-02-23 | Ms. Brittany HankamerExec. VP & Chief HR Officer | -1,68k | 15,04k | Sale to Issuer | 8,89 - 9,11 | 249,05k | -0,67% |
| 2026-02-19 | Mr. Gregory Thomas LucierIndependent Director | 50,00k | 458,00k | Achat | 9,16 | 50,00k | - |
| 2026-02-20 | Mr. Steven W. EckSenior VP, Interim CFO, Corporate Controller & CAO | -2,13k | 19,19k | Sale to Issuer | 9,03 | 101,80k | -2,04% |
| 2026-02-20 | Ms. Brittany HankamerExec. VP & Chief HR Officer | -1,45k | 13,12k | Sale to Issuer | 9,03 | 250,73k | -0,58% |
| 2026-02-20 | Mr. Claudius O. SokenuExec. VP, Corporate Secretary and Chief Legal & Compliance Officer | -2,92k | 26,36k | Sale to Issuer | 9,03 | 19,27k | -13,16% |
| 2026-02-20 | Mr. Corey D. WalkerPresident of Laboratory Solutions | -4,96k | 44,82k | Sale to Issuer | 9,03 | 16,02k | -23,65% |
| 2026-02-20 | Mr. R. Brent JonesInitié | -9,51k | 85,84k | Sale to Issuer | 9,03 | 34,20k | -21,75% |
| 2026-02-20 | Mr. Benoit GourdierExec. VP of Bioscience Production | -4,16k | 37,56k | Sale to Issuer | 9,03 | 19,33k | -17,71% |
| 2026-02-12 | Mr. Gregory L. SummeIndependent Chairman of the Board | 100,00k | 940,00k | Achat | 9,40 | 441,01k | 29,32% |
| 2025-12-05 | Mr. Sanjeev Kishen MehraIndependent Director | 350,00k | 3,88M | Achat | 11,09 | 350,00k | - |
| 2025-11-17 | Mr. Emmanuel LignerPresident, CEO & Director | 87,50k | 993,13k | Achat | 11,35 | 87,50k | - |
| 2025-10-30 | Mr. Gregory L. SummeIndependent Chairman of the Board | 100,00k | 1,13M | Achat | 11,25 | 341,01k | 41,49% |
| 2025-10-02 | Mr. Benoit GourdierExec. VP of Bioscience Production | -1,26k | 17,41k | Sale to Issuer | 13,77 | 11,58k | -9,84% |
| 2025-08-21 | Mr. Gregory L. SummeIndependent Chairman of the Board | 100,00k | 1,26M | Achat | 12,56 | 241,01k | 70,92% |
| 2025-08-14 | Ms. Brittany HankamerExec. VP & Chief HR Officer | -181,00 | 2,35k | Sale to Issuer | 12,98 | 171,56k | -0,11% |
| 2025-08-05 | Mr. Steven W. EckSenior VP, Interim CFO, Corporate Controller & CAO | -3,48k | 39,59k | Vente | 11,39 | 55,07k | -5,94% |
| 2025-07-31 | Mr. Steven W. EckSenior VP, Interim CFO, Corporate Controller & CAO | -1,39k | 18,61k | Sale to Issuer | 13,44 | 58,54k | -2,31% |
| 2025-07-24 | Mr. Claudius O. SokenuExec. VP, Corporate Secretary and Chief Legal & Compliance Officer | -3,12k | 43,75k | Sale to Issuer | 14,01 | 15,04k | -17,19% |
| 2025-06-21 | Mr. Corey D. WalkerPresident of Laboratory Solutions | -2,73k | 37,05k | Sale to Issuer | 13,57 | 6,69k | -28,99% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
